Bank of New York Mellon Corp - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$629,000
-5.1%
34,241
-5.3%
0.00%
Q3 2020$663,000
+18.4%
36,148
-3.3%
0.00%
Q2 2020$560,000
-0.5%
37,396
+5.0%
0.00%
Q1 2020$563,000
-0.7%
35,629
+2.0%
0.00%
Q4 2019$567,000
+16.7%
34,920
+6.7%
0.00%
Q3 2019$486,000
-24.1%
32,724
-15.4%
0.00%
Q2 2019$640,000
-5.0%
38,684
-0.7%
0.00%
Q1 2019$674,000
+0.7%
38,959
+2.9%
0.00%
Q4 2018$669,000
+13.2%
37,857
+16.3%
0.00%
Q3 2018$591,000
-12.6%
32,549
-5.9%
0.00%
Q2 2018$676,000
+243.1%
34,579
+208.1%
0.00%
Q1 2018$197,000
-58.5%
11,225
-72.1%
0.00%
Q1 2017$475,000
-8.1%
40,268
+1.9%
0.00%
Q4 2016$517,000
-3.2%
39,506
+7.2%
0.00%
Q3 2016$534,000
+17.9%
36,865
-2.2%
0.00%
Q2 2016$453,000
-26.1%
37,713
+14.8%
0.00%
Q1 2016$613,000
-12.3%
32,845
+0.9%
0.00%
Q4 2015$699,000
+26.9%
32,5550.0%0.00%
Q3 2015$551,000
-57.9%
32,555
-6.7%
0.00%
Q2 2015$1,309,000
+526.3%
34,897
+426.5%
0.00%
Q1 2015$209,0006,6280.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2019
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders